FDA Disclaimer
Required FDA Statement
These statements have not been evaluated by the Food and Drug Administration. MemoVolt is not intended to diagnose, treat, cure, or prevent any disease.
Dietary Supplement Classification
MemoVolt is classified as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Dietary supplements are not drugs and are not required to undergo the same FDA approval process as pharmaceutical products.
Manufacturing Standards
MemoVolt is manufactured in the United States at a facility that is:
- Registered with the US Food and Drug Administration
- Certified under Good Manufacturing Practices (GMP)
- Compliant with USDA National Organic Program handling standards
Registration and GMP certification apply to the facility and its processes, not to any FDA endorsement of individual products.
Health Claims Policy
Any information about MemoVolt on this website is provided for educational purposes only. It is not intended as a substitute for advice from your physician or other healthcare professional. You should not rely upon information on this website for medical diagnosis or treatment of any health issue.
Do not disregard, avoid, or delay obtaining medical or health-related advice from your healthcare professional because of something you have read on this site.
Consult with a qualified healthcare provider before starting any new supplement, particularly if you:
- Have a diagnosed medical condition
- Take prescription medications
- Are pregnant or nursing
- Are under 18 years of age
- Are scheduled for surgery within 2 weeks
Individual Results
Results from using MemoVolt vary from person to person. Individual factors including diet, activity level, sleep, genetics, and overall health influence how any dietary supplement performs. Testimonials on this site represent individual experiences and do not guarantee similar results.
Reporting Adverse Events
If you experience any adverse reaction to MemoVolt or any other dietary supplement, discontinue use and consult a healthcare provider. Serious adverse events may also be reported to the FDA MedWatch program at 1-800-FDA-1088 or online at fda.gov/safety/medwatch.